aztreonam has been researched along with Bone Diseases, Infectious in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Bone Diseases, Infectious: Bone diseases caused by pathogenic microorganisms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rigo-Bonnin, R | 1 |
| Canalias, F | 1 |
| El Haj, C | 1 |
| González-Hernando, MC | 1 |
| Díaz-Troyano, N | 1 |
| Soldevila, L | 1 |
| Benavent, E | 1 |
| Murillo, O | 1 |
1 other study available for aztreonam and Bone Diseases, Infectious
| Article | Year |
|---|---|
Measurement uncertainty of β-lactam antibiotics results: estimation and clinical impact on therapeutic drug monitoring.
Topics: Anti-Bacterial Agents; Aztreonam; Bone Diseases, Infectious; Cefepime; Chromatography, High Pressure | 2020 |